Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A lymphangioma characterized by the presence of collagen bundle formation. It has an indolent clinical course and may be associated with skin plaques.
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and gene therapy. Pipeline includes 2 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
5 publications have been identified in PubMed for lymphangioendothelioma. Research spans Case Report / Case Series (80%) and Basic Science / Preclinical (20%).
Tran LD (2026). [PMID: 41732542](https://pubmed.ncbi.nlm.nih.gov/41732542/). *Radiol Case Rep*. [Case Report / Case Series]
Wen X (2025). [PMID: 40518862](https://pubmed.ncbi.nlm.nih.gov/40518862/). *J Dermatolog Treat*. [Basic Science / Preclinical]
Yorita K (2024). [PMID: 39347342](https://pubmed.ncbi.nlm.nih.gov/39347342/). *Cureus*. [Case Report / Case Series]
Kummari S (2024). [PMID: 39737324](https://pubmed.ncbi.nlm.nih.gov/39737324/). *Cureus*. [Case Report / Case Series]
Mitchell R (2024). [PMID: 38910734](https://pubmed.ncbi.nlm.nih.gov/38910734/). *Cureus*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:04 PM UTC